1. Modic MT, Ross JS. Lumbar degenerative disk disease. Radiology. 2007;245(1):43-61.
2. Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356-67.
3. Wang F, et al. Aging and degenerative changes of intervertebral disc. Int J Mol Sci. 2016;17(8):1324.
4. Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it? Spine. 2006;31(18):2151-61.
5. Buckwalter JA. Aging and degeneration of the human intervertebral disc. Spine. 1995;20(11):1307-14.
6. Vo NV, Hartman RA, Patil PR, Risbud MV, Kletsas D, Iatridis JC, et al. Molecular mechanisms of biological aging in intervertebral discs. J Orthop Res. 2016;34(8):1289-306.
7. Eskola PJ, et al. Genetic risk factors in symptomatic lumbar disc disease. Spine. 2010;35(11):1234-238.
8. Hangai M, et al. Age-related changes in the lumbar intervertebral discs and their association with low back pain: a large-scale population-based study. Osteoarthritis Cartilage. 2008;16(8):994-1000.
9. Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol. 2014;10(1):44-56.
10. Videman T, et al. The relative roles of inheritance and physical load in degenerative changes of the lumbar spine. Spine. 2005;30(6):697-703.
11. Sowa GA, et al. Epigenetic changes in intervertebral disc disease. Front Cell Dev Biol. 2020;8:580186.
12. Samartzis D, et al. The biology of disc degeneration: genetics and beyond. J Orthop Res. 2015;33(9):1333-45.
13. Urban JPG, Roberts S. Degeneration of the intervertebral disc. Arthritis Res Ther. 2003;5(3):120-30.
14. Raj PP. Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Pract. 2008;8(1):18-44.
15. Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV, Anderson DG. The molecular basis of intervertebral disc degeneration. Spine J. 2013;13(3):318-30.
16. Wang DL, et al. The effects of static load on intervertebral disc degeneration in a rat tail model. Spine. 2007;32(23):E667-E673.
17. Fields AJ, et al. Role of metabolic syndrome and its components in the development of spine disease. J Bone Joint Surg Am. 2015;97(10):760-68.
18. Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368-83.
19. Gruber HE, et al. Apoptosis in intervertebral disc degeneration. Spine J. 2002;2(4):252-260.
20. Wang F, et al. Inflammation and oxidative stress in intervertebral disc degeneration: molecular insights and therapeutic targets. J Orthop Translat. 2020;24:83-93.
21. Kim H, et al. Programmed necrosis, not apoptosis, is responsible for the cell death in disc degeneration. J Orthop Res. 2021;39(1):86-96.
22. Sambrook PN, MacGregor J, Spector TD. Genetic influences on cervical and lumbar disc degeneration: a magnetic resonance imaging study in twins. Arthritis Rheum. 1999;42(2):366-72.
23. Solovieva S, et al. IL1 gene cluster polymorphisms and intervertebral disc degeneration: results from a Finnish population sample. J Med Genet. 2004;41(2):e21.
24. Videman T, et al. The association of VDR and COL9A2 gene polymorphisms with lumbar disc degeneration. Spine. 2001;26(23):2487-91.
25. Liu ZH, et al. DNA methylation status of the ACAN gene promoter influences the degeneration of human intervertebral disc. PLoS One. 2014;9(1):e85766.
26. Song YQ, et al. The role of microRNAs in intervertebral disc degeneration. Orthop Surg. 2020;12(2):445-54.
27. Song YQ, et al. MicroRNA-155 regulates inflammatory responses in nucleus pulposus cells by targeting TCF4. Spine. 2021;46(1):E21-E29.
28. Song YQ, et al. Nanoparticle-mediated delivery of miR-199a inhibits degeneration of intervertebral discs in rats. Biomaterials. 2020;245:119978.
29. Song YQ, et al. miR-21 promotes matrix degradation in intervertebral disc degeneration by targeting PTEN. J Orthop Res. 2019;37(6):1263-73.
30. Gruber HE, et al. Increased cell senescence is associated with decreased cell proliferation in vivo in the degenerating human annulus. Spine J. 2010;10(10):849-56.
31. Fang F, et al. Oxidative stress and intervertebral disc degeneration: evidence from antioxidant therapies. Oxid Med Cell Longev. 2022;2022:6694380.
32. Le Maitre CL, et al. Altered gene expression in human nucleus pulposus cells isolated from degenerate intervertebral disc. Spine. 2007;32(17):1744-51.
33. Wang J, et al. Inflammatory cytokines induce ADAMTS-5 and MMP expression in human intervertebral disc cells. J Orthop Res. 2014;32(6):965-72.
34. Illien-Jünger S, et al. Diabetes mellitus increases susceptibility to intervertebral disc degeneration by oxidative stress, inflammation, and accelerated cell senescence. Spine. 2013;38(14):E869-E881.
35. Binch AL, et al. Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. Spine. 2015;40(9):593-600.
36. Zhang W, et al. Anti-inflammatory and antioxidant effects of resveratrol on intervertebral disc degeneration: in vitro and in vivo studies. Cell Physiol Biochem. 2018;47(2):849-63.
37. Yang SH, et al. Curcumin attenuates matrix degradation via the inhibition of the NF-κB pathway in interleukin-1β-induced human nucleus pulposus cells. Int J Mol Med. 2018;42(2):755-764.
38. Iatridis JC, et al. Degeneration of the intervertebral disc with aging. Orthop Clin North Am. 2011;42(4):561-71.
39. Le Maitre CL, et al. Expression of matrix metalloproteinases and their inhibitors in the human intervertebral disc: implications for disc degeneration. Arthritis Res Ther. 2007;9(3):R83.
40. Antoniou J, et al. The role of cytokines in disc degeneration. Spine. 1996;21(8):863-79.
41. Illien-Jünger S, et al. AGEs induce abnormal stiffening of the human nucleus pulposus in vitro. Spine. 2013;38(17):E1040-E1047.
42. Yurube T, et al. Emerging treatments for intervertebral disc degeneration targeting cytokines, epigenetics, and ECM. JOR Spine. 2020;3(2):e1083.
43. Johnson WE, et al. Immunohistochemical study of cytokines in human intervertebral discs: implications for disc degeneration and repair. Spine. 2001;26(5):593-99.
44. Shamji MF, Setton LA, Jarvis W, So S, Chen J, Jing L, et al. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 2010;62(7):1974-82.
45. Risbud MV, et al. Inflammatory cytokines and matrix degrading enzymes in intervertebral disc degeneration: cause or effect? Global Spine J. 2014;4(3):145-58.
46. Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O’Brien J, Jayson MI. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 1997;350(9072):178-81.
47. Lee JM, et al. The role of VEGF and angiogenesis in disc degeneration. J Bone Joint Surg Am. 2011;93(9):847-55.
48. Chen C, et al. Targeting angiogenesis and nerve ingrowth in intervertebral disc degeneration: therapeutic implications. Bone Res. 2022;10(1):45.
49. Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine. 2001;26(17):1873-8.
50. Griffith JF, Wang YXJ, Antonio GE, Choi KC, Yu A, Ahuja AT, et al. Modified Pfirrmann grading system for lumbar intervertebral disc degeneration. Spine. 2007;32(24):E708-E712.
51. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology. 1988;166(1):193-9.
52. Jensen TS, et al. Modic changes and disc degeneration in patients with low back pain. Eur Spine J. 2008;17(6):1029-42.
53. NASS/ASNR/ASSR. Disc nomenclature version 2.0: recommendations of the combined task forces. Spine J. 2014;14(11):2525-45.
54. Brinjikji W, Diehn FE, Jarvik JG, Carr CM, Kallmes DF, Murad MH, et al. MRI findings of disc degeneration are more prevalent in adults with low back pain than in asymptomatic controls: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2015;36(12):2394-9.
55. Belavý DL, Quittner MJ, Ridgers N, Ling Y, Connell D, Rantalainen T. Running exercise strengthens the intervertebral disc. Sci Rep. 2017;7(1):45975.
56. Belavý DL, et al. Resistance training and lumbar disc health: a systematic review of controlled trials. Eur Spine J. 2021;30(2):233-49.
57. Lugo JP, et al. Undenatured type II collagen for joint support: a review of published studies. Complement Ther Med. 2016;29:57-62.
58. Luo L, et al. The efficacy of chondroitin sulfate and glucosamine for osteoarthritis: meta-analysis. J Orthop Surg Res. 2018;13(1):170.
59. Li Y, et al. Epigenetic regulation in nucleus pulposus cells: implications for intervertebral disc degeneration. Eur Cell Mater. 2016;22:226-37.
60. Noriega DC, Ardura F, Hernández-Ramajo R, Martín-Ferrero MA, Sánchez-Lite I, Toribio B, et al. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation. 2017;101(8):1945-51.
61. Pettine KA, et al. Autologous bone marrow concentrate injection in patients with discogenic low back pain: a prospective trial. Pain Physician. 2015;18(1):E19-E32.
62. Sloan SR, et al. Emerging regenerative approaches for intervertebral disc repair and regeneration. Curr Rev Musculoskelet Med. 2017;10(1):14-21.
63. Wang F, et al. Gene therapy for intervertebral disc degeneration: an overview of current advances and future directions. Gene Ther. 2015;22(10):547-56.
64. Périé D, et al. Injectable biomaterials for intervertebral disc regeneration: focus on minimally invasive strategies. Biomaterials. 2021;276:121018.
65. Jamaludin A, et al. Using deep learning to detect lumbar disc degeneration and predict clinical outcomes from spinal MRI: preliminary results. Eur Spine J. 2020;29(8):1866-73.
66. Fields AJ, et al. Diet-induced obesity causes metabolic changes and degenerative remodeling in the intervertebral disc. J Orthop Res. 2015;33(5):703-11.
67. Gantenbein B, et al. Nutritional modulation of intervertebral disc health. Nutrients. 2021;13(6):1824.
68. Xu H, et al. Ketogenic diet attenuates intervertebral disc degeneration in a rat model. Spine. 2022;47(5):E184-E192.
69. Wang Z, et al. Caloric restriction and intermittent fasting: potential for prevention of intervertebral disc degeneration. Front Nutr. 2021;8:689408.
70. Li Y, et al. Nutritional interventions in the management of intervertebral disc degeneration: current perspectives. Eur J Clin Nutr. 2022;76(1):23-33.